On the basis of these findings that LncTCF7 impacts the biological processes of HCC via the TCF7/Wnt/β-catenin axis, it could be a promising therapeutic target to effectively improve the prognosis of HCC patients. Here, WSPAR is linked to hepatocellular carcinoma.